Successful trial results for the Oxford University/AstraZeneca vaccine, suggesting it could protect up to 90% of people, are the third set of promising findings in as many weeks. The vaccine is low-cost, at £3 a dose compared with more than £20 for the Pfizer/BioNTech and Moderna vaccines, which also released results this month. It has been a privilege to be part of this multinational effort, which will reap benefits for the whole world.”Quick Guide Who in the UK will get the new Covid-19 vaccine first? “To have interim results from three vaccine teams within a year is incredible, and testament to a truly extraordinary global scientific effort. “To meet the aim of vaccinating high-risk populations around the world over the next year we need at least 2bn vaccine doses.”

Source: The Guardian November 23, 2020 20:34 UTC